Overview
WAVi develops non-invasive neuromodulation devices designed to treat neurological and psychiatric conditions through targeted brain stimulation. The company's technology platform focuses on delivering therapeutic interventions with enhanced precision and patient outcomes.
More in Neurotechnology
Latest industry news
New Accelerator Seeks to Bring Neurotech Startups From Lab to Market Faster
2026-09-06 · Industry
China Accelerates Its Brain-Computer Interface Ambitions in a Major National Push
2026-09-05 · Industry
Tether Evo Tackles Brain-Computer Interface's Most Stubborn Engineering Problem
2026-09-04 · Research
FDA Grants De Novo Approval to Modius Spero, Clearing First Neuromodulation Device for PTSD
2026-09-03 · Policy
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →